School of Medicine

WashU Medicine faculty and research members of Siteman Cancer Center have identified a previously unknown population of aggressive tumor cells in difficult-to-treat head and neck cancers.

WashU Medicine infectious diseases expert Michael Diamond, MD, PhD, has won a $2.5 million prize to advance the development of drugs to treat debilitating chikungunya and related viruses.

The funding will support a WashU Medicine collaboration with CRISPR Therapeutics and SynGenix, a WashU startup, to move a single-injection treatment to reverse joint damage into clinical trials.

A study in mice by WashU Medicine researchers advances efforts to shield infants from Klebsiella pneumoniae, a dangerous bacterium that causes severe bloodstream infections and is the leading killer of children globally.

WashU Medicine psychiatry researcher Jan Kubanek was recognized with the One Mind Rising Star Award for his work on applying ultrasound to map and modulate brain circuits involved in depression.

A study led by Laura Marks, MD, and Madeline McCrary, MD, of WashU Medicine, shows that an oral antiviral regimen can be used safely and effectively in pregnant patients with hepatitis C virus.

WashU Medicine researchers have discovered that the ratio between two types of white blood cells can predict whether a person stays healthy as they age or faces an increased risk of disease.

A WashU Medicine radiologist is on a mission to expand a minimally invasive procedure called cryoablation as a safe option for patients.

WashU Medicine researchers show in a new study that brain cells called astrocytes modulate the supply of cholesterol in the brain to help neurons communicate.

First-year WashU Medicine MD and MD/PhD students received their white coats at a ceremony Oct. 2. Other ceremonies recognized incoming students studying physical therapy, occupational therapy and audiology.